Herbert

U.S. Non-Profit Foundation acquires John Collier's controversial painting, "The Laboratory"

Retrieved on: 
Thursday, September 21, 2023
The Laboratory, Culture, Imagination, Gothic, Herbert Art Gallery and Museum, Woman, Guildhall Art Gallery, Myth, Sale, Christie's, Herbert, Acquisition, Collection, Poisoning, Marquess, Imagination Foundation, Laboratory, Female, Entertainment, Interior design, Collier

LOS ANGELES, Sept. 21, 2023 /PRNewswire/ -- The Arts of Imagination Foundation today announced their acquisition of John Collier's artistic masterwork, The Laboratory , in a private sale negotiated by Christie's in New York.

Key Points: 
  • LOS ANGELES, Sept. 21, 2023 /PRNewswire/ -- The Arts of Imagination Foundation today announced their acquisition of John Collier's artistic masterwork, The Laboratory , in a private sale negotiated by Christie's in New York.
  • The 1895 oil painting is an instantly recognizable example of Victorian Gothic art and has rarely been displayed publicly.
  • Its striking visuals and roots in storytelling played a vital role in the Arts of Imagination Foundation's decision to make The Laboratory part of their permanent collection.
  • The painting will be publicly available as part of the Foundation's continuing efforts to illuminate how stories and art influence our culture and inspire personal discovery.

Tetrate Chosen by United States Air Force to Speed Delivery of Secure and Compliant Software Applications in $1.75M Contract

Retrieved on: 
Tuesday, May 16, 2023
NIST, AFSPC, U.S. Department of Defense Strategy for Operating in Cyberspace, OIDC, Partnership, SSO, USAF, Defense, Single sign-on, Air Force Life Cycle Management Center, United States Department of Defense, TLS, Policy, DC, Space Operations Command, Organization, ZTA, Student, Federal law enforcement in the United States, National Institute of Standards and Technology, Atmosphere of Earth, Commerce, SAN, Zero trust security model, Tetration, TIS, FIPS, OpenID, Air force, Service mesh, Federation, United States Department of the Air Force, Herbert, Safety, Air Force Space Command Space Operations Squadron, Cryptocurrency, Medical device, DevOps

SAN FRANCISCO, May 16, 2023 /PRNewswire-PRWeb/ -- Tetrate, the provider of the world's leading application networking and security platform, today announced the renewal of its contract with the United States Air Force (USAF). The total annual contract value exceeds $1.7 million for services and support. Tetrate supports USAF "Platform One" with application networking and security services with Tetrate Istio Subscription (TIS), a product based on open source Istio service mesh and Envoy proxy, services essential for implementing a Zero Trust security model.

Key Points: 
  • SAN FRANCISCO, May 16, 2023 /PRNewswire-PRWeb/ -- Tetrate, the provider of the world's leading application networking and security platform, today announced the renewal of its contract with the United States Air Force (USAF).
  • Platform One is a software development platform used by the USAF to build secure and compliant software applications.
  • It is used by various USAF organizations, including the Air Force Life Cycle Management Center (AFLCMC) and the Air Force Space Command (AFSPC).
  • "Tetrate is honored to be chosen once again by the U.S. Air Force to continue contributing to the security of Platform One," said Branden Wood, federal director at Tetrate.

Vivante Adds Prominent Gastroenterology Specialists to Clinical Advisory Board

Retrieved on: 
Monday, May 8, 2023
Gastrointestinal cancer, Vivante Corporation, Gastroenterology, Epidemiology, Biotechnology, Columbia University Irving Medical Center, Health, David Geffen School of Medicine at UCLA, Quality of life, DRS, Johns Hopkins School of Medicine, Research, Irritable bowel syndrome, National Cancer Institute, Physician, IBS, Stanford University Medical Center, Machine learning, Colorectal cancer, Drug discovery, Diagnosis, Growth, UCLA, Herbert, Pharmaceutical industry, Nursing, Medicine

CHICAGO, May 8, 2023  /PRNewswire/ -- Vivante Health, the leading provider of digital digestive health solutions for employers and health plans, today announced the addition of Dr. Chin Hur and Dr. Uri Ladabaum to the company's clinical advisory board. Both physicians hold professorships at top university medical centers and have conducted extensive research into gastrointestinal diseases.

Key Points: 
  • CHICAGO, May 8, 2023 /PRNewswire/ -- Vivante Health , the leading provider of digital digestive health solutions for employers and health plans, today announced the addition of Dr. Chin Hur and Dr. Uri Ladabaum to the company's clinical advisory board.
  • Both join Vivante's clinical advisory board at a time when the company is preparing to launch industry-first enhancements to its GIThrive digital digestive health platform.
  • Hur and Ladabuam are nationally recognized clinical and research leaders in gastroenterology who are at the forefront of innovation in the field.
  • "I look forward to working with them and our entire clinical advisory board so we can continue to provide the highest quality care for the members we serve."

Tetrate, NIST, Department of Commerce to host 4th Annual Multi-Cloud Conference and Workshop

Retrieved on: 
Thursday, March 30, 2023
Cloud, NIST, United States Department of Commerce, Partnership, Host Based Security System, Ronald Reagan Building and International Trade Center, Face, Policy, EDT, Ronald Reagan, Government, Workshop, ZTA, Student, NIST Special Publication 800-53, Trust, Identity, Commerce, SAN, Service mesh, Mathematical Applications Group, Conference, Herbert, Medical device, Tetration

SAN FRANCISCO , March 30, 2023 /PRNewswire-PRWeb/ -- Tetrate - the company driving zero trust architecture, accelerating enterprise service mesh adoption, and reducing hybrid cloud complexity - announces the fourth annual conference on zero trust architecture (ZTA) and high assurance for cloud-native applications. Hosted by Tetrate in partnership with the Department of Commerce and the U.S. National Institute of Standards and Technology (NIST), the 4th Annual Multi-Cloud Conference and Workshop is a premier event for cybersecurity professionals, policy makers, entrepreneurs and students.

Key Points: 
  • Hosted by Tetrate in partnership with the Department of Commerce and the U.S. National Institute of Standards and Technology (NIST), the 4th Annual Multi-Cloud Conference and Workshop is a premier event for cybersecurity professionals, policy makers, entrepreneurs and students.
  • "The 4th Annual Multi-Cloud Conference and Workshop will offer perspectives on the security challenges that public agencies face and provide insight and know-how to address these challenges."
  • This workshop will teach the basics of service mesh using the widely adopted Istio service mesh based on the modern Envoy proxy.
  • Participants can expect to leave the workshop with the ability to:
    Understand the high-level architecture and components of technology solutions (e.g., Istio)

Boston Children's Hospital names Wendy Chung, MD, PhD, Chief of the Department of Pediatrics

Retrieved on: 
Tuesday, February 14, 2023
HMS, Medical director, Cornell University, Mentorship, Columbia University Irving Medical Center, Simons Foundation Autism Research Initiative, SPARK, Personalized medicine, Organization, Weill Cornell Medicine, Boston, NIH, Division, Columbia University, Education, Teaching, Hospital, Rockefeller University, Harvard Medical School, Morgan Stanley Children's Hospital, Research, SFARI, Genetics, Herbert Irving Comprehensive Cancer Center, Associate, Spectrum, Economics, Herbert, Doctor of Philosophy, Nursing, Pediatrics, Biochemistry, Boston Children's Hospital, Medicine, MD

BOSTON, Feb. 14, 2023 /PRNewswire/ -- Boston Children's Hospital has named Wendy Chung, MD, PhD, the hospital's next Chief of the Department of Pediatrics.

Key Points: 
  • BOSTON, Feb. 14, 2023 /PRNewswire/ -- Boston Children's Hospital has named Wendy Chung, MD, PhD, the hospital's next Chief of the Department of Pediatrics.
  • Dr. Chung will be responsible for leadership, strategy, oversight, and vision for the Department of Pediatrics, ensuring alignment with the goals, strategic priorities and mission of Boston Children's, the Physician's Organization, and Harvard Medical School.
  • In addition to her role as Chief of the Department of Pediatrics, Dr. Chung will serve as the Mary Ellen Avery Professor at Harvard Medical School (HMS), and President of the Children's Hospital Pediatric Associates.
  • "Dr. Chung is a tremendous addition to our Boston Children's team," says Kevin B. Churchwell, MD, President and CEO Boston Children's Hospital.

Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer

Retrieved on: 
Thursday, January 12, 2023
Regulatory T cell, Blood, Prostate cancer, Physician, Columbia University Irving Medical Center, Surgeon, Trial of the century, MDSC, Safety, TAAS, Columbia University Vagelos College of Physicians and Surgeons, MD, PSA, Herbert Irving Comprehensive Cancer Center, NK, Columbia University, Patient, Brachytherapy, Abstract, TME, OTCQX, Herbert, Columbia, Medicine, Prostate-specific antigen, LM, Pharmaceutical industry, Advaxis

MONMOUTH JUNCTION, N.J., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Advaxis, Inc. (OTCQX: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced an update on the Phase 1 clinical study evaluating ADXS-504, the company’s off-the-shelf neoantigen drug candidate, in patients with biochemically recurrent (early) prostate cancer that is being conducted at Columbia University Irving Medical Center. Karie Runcie, MD, assistant professor of medicine, and Mark N. Stein, MD, associate professor of medicine, in the division of hematology/oncology at Columbia University Vagelos College of Physicians and Surgeons and members of the Herbert Irving Comprehensive Cancer Center, are the study’s principal and senior investigators, respectively.

Key Points: 
  • The study design of this phase 1 open-label dose escalation study for patients in both dose cohorts was presented at the 2022 ASCO Annual Meeting by Dr. Runcie (Abstract #: TPS5115).
  • The trial is currently expanding enrollment at the second dose level by up to six additional patients for a total of nine patients.
  • “We have completed evaluation of the dose-limiting-toxicity period for three patients at the second dose level for this Phase 1 trial of ADXS-504.
  • We look forward to analyzing the composite data to gain further insight into the safety and efficacy of this novel therapy.”

SOUTHWEST AIRLINES AWARDS SCHOLARSHIPS TO PROVIDE EDUCATIONAL OPPORTUNITIES FOR STUDENTS

Retrieved on: 
Monday, December 5, 2022
Access Now, Inc. v. Southwest Airlines Co., Peoples Multi-purpose High School, Ankola, Navy Office of Community Outreach, Herbert, Heart, Silicon Valley Community Foundation, Southwest Airlines, NYSE, Hospitality, History, Air travel, Multimedia, Education, Silicon, Communication, Student, Carbon, Airport, Airline

DALLAS, Dec. 5, 2022 /PRNewswire/ -- Southwest Airlines Co. (NYSE: LUV) today announced recipients for the Herbert D. Kelleher and Rollin W. King Scholarship and the Southwest Airlines Scholarship. The scholarships champion the educational pursuits of students across the country, encouraging students to soar by providing educational access through these opportunities. Through these scholarships, Southwest has committed to awarding $260,000 over four years to the following 15 recipients and, as a fun surprise, each student also received four roundtrip tickets on Southwest to help them stay connected to their families throughout the year.

Key Points: 
  • (NYSE: LUV) today announced recipients for the Herbert D. Kelleher and Rollin W. King Scholarship and the Southwest Airlines Scholarship.
  • The scholarships champion the educational pursuits of students across the country, encouraging students to soar by providing educational access through these opportunities.
  • "We have seen the positive impact providing educational opportunities can have on both individuals and communities, and we are proud to support 15 students with scholarships this year," said Laurie Barnett,Vice President of Communications & Outreach at Southwest Airlines.
  • Funds awarded for both of these scholarships come from the Southwest Airlines Foundation, a corporate-advised fund at the Silicon Valley Community Foundation.

Global Coalition for Adaptive Research Announces That Regorafenib Has Completed Follow-up in the GBM AGILE Trial for Patients With Glioblastoma

Retrieved on: 
Wednesday, September 21, 2022
Science, Neurology, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, Probability, National Foundation for Cancer Research, Regorafenib, Department, Dean (education), MD, Center, New, Health, Clinical trial, GBM, Herbert, Glioblastoma, United Nations Foundation, Patient, UCLA, Cancer, National Brain Tumor Society, Department of Neurology, Xuanwu hospital, Surgeon, MGMT, Radiation, Leadership, Coalition, Principal investigator, Columbia University Irving Medical Center, Associate, Arm, Herbert Irving Comprehensive Cancer Center, Lomustine, Global Coalition Against Pneumonia, Neurology, Sponsor, Temozolomide, Dana–Farber Cancer Institute, Columbia, Pharmaceutical industry, Medical device, Physician

Global Coalition for Adaptive Research (GCAR), Sponsor of GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) master protocol, announced that regorafenib has completed enrollment and follow-up in GBM AGILE.

Key Points: 
  • Global Coalition for Adaptive Research (GCAR), Sponsor of GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) master protocol, announced that regorafenib has completed enrollment and follow-up in GBM AGILE.
  • Regorafenib was being evaluated in GBM AGILE for efficacy in patients with recurrent glioblastoma and in patients with newly diagnosed MGMT unmethylated glioblastoma.
  • GBM AGILE is an international, innovative platform trial designed to identify effective therapies more rapidly for patients with glioblastoma through response adaptive randomization and a seamless phase 2/3 design.
  • GCAR is the sponsor of GBM AGILE, an adaptive platform trial for patients with GBM the most common and deadliest of malignant primary brain tumors.

FAU CEREMONIOUSLY BREAKS GROUND ON FUTURE KURT AND MARILYN WALLACH HOLOCAUST AND JEWISH STUDIES BUILDING

Retrieved on: 
Monday, September 19, 2022
Jews, Empathy, Faculty, Human rights education, Education, Florida Atlantic University, U.S. News & World Report, Memory, Social justice, Dorothy, Atrocity, Justice, Foundation (nonprofit), Hope, Speech, News, Survivor, Dorothy F. Schmidt College of Arts and Letters, Hatred, Bias, Achievement, Holocaust studies, Herbert, Public expenditure, History, Breeding, Prejudice, Letter, College, Student, Arthur, Social change, FAU, BOCA, Carnegie Foundation for the Advancement of Teaching, Research, Leon, University, Carnegie Foundation, Mindfulness, Human rights, Pharmaceutical industry, Tourism, Interior design, Medicine, The Holocaust, Vlachs

BOCA RATON, Fla., Sept. 19, 2022 /PRNewswire/ -- Florida Atlantic University ceremoniously broke ground on its future Kurt and Marilyn Wallach Holocaust and Jewish Studies Building today at its Boca Raton campus.

Key Points: 
  • BOCA RATON, Fla., Sept. 19, 2022 /PRNewswire/ -- Florida Atlantic University ceremoniously broke ground on its future Kurt and Marilyn Wallach Holocaust and Jewish Studies Building today at its Boca Raton campus.
  • "The first is to honor the memory of the more than 200 members of my husband's family that were murdered in the Holocaust.
  • Our world today is full of hate, and that is the breeding ground for the next Holocaust.
  • "We are honored and grateful for Kurt and Marilyn Wallach's enormous generosity," said FAU President John Kelly.

Knowles Elects Science Education Scholar & Prominent Physician and Researcher as Trustees

Retrieved on: 
Monday, September 12, 2022
Friends' Central School, Hematology-Oncology and Stem Cell Transplantation Research Center, Faculty, Summer Enrichment Program (University of Colorado), Doctor of Philosophy, University, Cell biology, Director, New, Pediatrics, Augustus A. Bird, University of Michigan, Philosophy, Mathematics, Learning, Herbert, Harvard Graduate School of Education, Harvard University, Curriculum, University Medical Center, Happiness, Student, Leadership, Board of directors, Science, Friends, Board, Pathology, Associate, Herbert Irving Comprehensive Cancer Center, Harvard Educational Review, University of Washington Department of Bioengineering, Haverford College, Francis, Microbiology, Education, Chemistry, Tutoring, Trustee, Yale University, Medicine

"Both Dr. Braaten and Dr. Emerson are highly accomplished in the fields of science and education," said Lawrence Tint , Knowles Board of Trustees Chairman.

Key Points: 
  • "Both Dr. Braaten and Dr. Emerson are highly accomplished in the fields of science and education," said Lawrence Tint , Knowles Board of Trustees Chairman.
  • Previously, she worked as an assistant professor and director of the secondary science education program at the University of Wisconsin, Madison.
  • Notably, she co-authored a widely read and influential book, Ambitious Science Teaching (2018), through Harvard Education Press.
  • in education, both from the University of Tennessee, Knoxville, and a Ph.D. in curriculum and instruction and science education from the University of Washington.